Dr. Blaschke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
855 Allardice Way
Stanford, CA 94305Phone+1 650-575-8364- Is this information wrong?
Education & Training
- University of California (San Francisco) School of MedicineResidency, Clinical Pharmacology, 1972 - 1974
- NCI NIHNone, Clinical Associate, 1970 - 1972
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1969 - 1970
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 1968 - 1969
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1968
Certifications & Licensure
- CA State Medical License 1972 - 2016
Publications & Presentations
PubMed
- 1 citationsIntroduction to the Theme "Pharmacological Individuality: New Insights and Strategies for Personalized and Precise Drug Treatment".Urs A Meyer, Susan G Amara, Terrence F Blaschke, Paul A Insel> ;Annual Review of Pharmacology and Toxicology. 2024 Jan 23
- 2 citationsClinical and epidemiological correlates of treatment change in patients with NMOSD: insights from the CIRCLES cohort.Shervin Gholizadeh, Alex Exuzides, Katelyn E Lewis, Chella Palmer, Michael Waltz, John W Rose, Anna Marie Jolley, Jacinta M Behne, Megan K Behne, Terrence F Blaschke, ...> ;Journal of Neurology. 2023 Apr 1
- Introduction to the Theme "Development of New Drugs: Moving from the Bench to Bedside and Improved Patient Care".Terrence F Blaschke, Paul A Insel, Susan G Amara, Urs A Meyer> ;Annual Review of Pharmacology and Toxicology. 2023 Jan 20
- Join now to see all
Grant Support
- Training Program In Clinical PharmacologyNational Institute Of General Medical Sciences1985–2002
- Interactions Between Protease Inhibitors/ Lipid LoweringNational Center For Research Resources2000–2001
- Test Effect Of Effect Of Nfv, Rtv &Soft Gel SqvNational Center For Research Resources1999–2000
- Oral L Arginine AdministrationNational Center For Research Resources1997–1999
- Vascular Responsiveness With The Use Of The Hand-Vein TechniqueNational Center For Research Resources1997
- Intravenous And Oral L-Arginine In Normal VolunteersNational Center For Research Resources1997
- Effect Of Smoking Cessation On Vascular ReactivityNational Center For Research Resources1997
- Aging And In Vivo Vascular ResponsivenessNational Institute On Aging1994–1995
- Aging And In Vivo Vascular Responsiveness In ManNational Institute On Aging1985–1993
- Clinical PharmacologyNational Institute Of General Medical Sciences1988–1992
- Aging And In Vivo Vascular Responsiveness In MenNational Institute On Aging1988–1991
- Mentor: Computerized Monitoring Of Therapeutic DecisionAgency For Healthcare Research And Quality1988–1989
- Kinetics Of Drug-Drug And Drug-Disease InteractionsNational Institute Of General Medical Sciences1986–1989
- Use Of Prophet II With A SUN 3/110 Lc-P5 WorkstationNational Center For Research Resources1987
- Mentor Computerized Monitoring Of Therapeutic DecisionsAgency For Healthcare Research And Quality1985–1987
- Ketoconazole Administration On Metabolism Of Antipyrine And CaffeineNational Center For Research Resources1985
- Antipyrine Disposition During Interferon AdministrationNational Center For Research Resources1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: